Analytical control of wollastonite for biomedical applications by use of atomic absorption spectrometry and inductively coupled plasma atomic emission spectrometry

被引:31
作者
De Aza, PN [1 ]
Guitián, F [1 ]
De Aza, S [1 ]
Valle, FJ [1 ]
机构
[1] CSIC, Inst Ceram & Vidrio, E-28500 Madrid, Spain
关键词
wollastonite; pseudowollastonite; biomaterials; impurities analysis; cold vapour atomic absorption spectrometry; hydride generation atomic absorption spectrometry; inductively coupled plasma atomic emission spectrometry;
D O I
10.1039/a708445e
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Preliminary in vitro experiments revealed that wollastonite (CaSiO3) is a potentially highly bioactive material that forms a hyroxyapatite (HA) surface layer on exposure to simulated body fluid with an ion concentration, pH and temperature virtually identical with those of human blood plasma. The formation of the HA layer is an essential requirement for an artificial material to be used as bioactive bone substitute, This finding opens up a wide field for biomedical applications of wollastonite, Biomaterials used as implants in the human body require strict control of trace elements and of the toxic species specified in American Society for Testing and Materials F-1185-88 (As, Cd, Hg and Pb) in ceramic hydroxyapatite for surgical implantation. In this work, two types of pseudowollastonite, the high temperature form of wollastonite, mere analysed by using cold vapour atomic absorption spectrometry and hydride generation atomic absorption spectrometry, in order to determine the elements stated in the above-mentioned norm, and inductively coupled plasma atomic emission spectrometry to establish the SiO2/CaO ratio of the two materials and analyse for all other impurities introduced by the raw materials and by the processes of synthesis, sintering and grinding, Barium and Mg were especially prominent in raw materials, and Zr, Y, Mg, W, Co and Ni come mainly from the processing.
引用
收藏
页码:681 / 685
页数:5
相关论文
共 19 条
[1]  
*ASTM, 1988, 118588 F ASTM
[2]  
BOUMANS PWJ, 1987, INDUCTIVELY COUPLED, P102
[3]   BIOACTIVITY OF WOLLASTONITE CERAMICS - IN-VITRO EVALUATION [J].
DEAZA, PN ;
GUITIAN, F ;
DEAZA, S .
SCRIPTA METALLURGICA ET MATERIALIA, 1994, 31 (08) :1001-1005
[4]   Morphological studies of pseudowollastonite for biomedical application [J].
DeAza, PN ;
Luklinska, ZB ;
Anseau, M ;
Guitian, F ;
DeAza, S .
JOURNAL OF MICROSCOPY, 1996, 182 :24-31
[5]   Bioceramics - Simulated body fluid interfaces: pH and its influence of hydroxyapatite formation [J].
DeAza, PN ;
Guitian, F ;
Merlos, A ;
LoraTamayo, E ;
DeAza, S .
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 1996, 7 (07) :399-402
[6]  
DEAZA PN, 1995, ADV SCI TECHNOLOGY, V12, P9
[7]  
DEVESA L, COMMUNICATION
[8]   THE INTERFACE OF VARIOUS GLASSES AND GLASS-CERAMICS WITH A BONY IMPLANTATION BED [J].
GROSS, U ;
STRUNZ, V .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1985, 19 (03) :251-271
[9]  
GROSS U, 1988, CRC CRITICAL REV BIO, V4, P2
[10]  
Hench L. L., 1993, ADV SERIES CERAMICS, V1, P1